Abstract
We report a patient who presented with superficial bladder tumors 8 years after cardiac transplantation. He was managed conservatively with intra-vesical therapy for 5 years and ultimately underwent a successful radical cystoprostatectomy and urethrectomy 13 years after cardiac transplantation. This illustrates that cardiac transplant patients with superficial tumors may be managed with conservative therapies, but close vigilance is necessary to identify the opportune time for extirpative surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Penn I (2000). Post-transplant malignancy: the role of immunosuppression. Drug Saf 23: 101–113
Baldwin DD and Ruckle HC (1995). Invasive bladder cancer following cardiac transplantation. Urol 46: 570–572
Stein JP, Skinner EC and Freeman JA (1995). Radical cystectomy and lower urinary tract reconstruction after cardiac allograft transplantation. J Urol 153: 415–416
Esrig D, Freeman JA and Elmajian DA (1996). Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 156: 1071–1076
Ladaga L and Schellhammer PF (1988). Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. J Urol 139: 290–293
Hassan JM and Cookson MS (2004). Urethral recurrence in patients following orthotopic urinary diversion. J Urol 172: 1338–1341
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhanani, N.N., Kamat, A.M. Treatment of bladder cancer in cardiac transplant patients. Int Urol Nephrol 38, 477–479 (2006). https://doi.org/10.1007/s11255-005-4978-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-005-4978-3